Correlation Between Armata Pharmaceuticals and PDS Biotechnology
Can any of the company-specific risk be diversified away by investing in both Armata Pharmaceuticals and PDS Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Armata Pharmaceuticals and PDS Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Armata Pharmaceuticals and PDS Biotechnology Corp, you can compare the effects of market volatilities on Armata Pharmaceuticals and PDS Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Armata Pharmaceuticals with a short position of PDS Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Armata Pharmaceuticals and PDS Biotechnology.
Diversification Opportunities for Armata Pharmaceuticals and PDS Biotechnology
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Armata and PDS is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Armata Pharmaceuticals and PDS Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PDS Biotechnology Corp and Armata Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Armata Pharmaceuticals are associated (or correlated) with PDS Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PDS Biotechnology Corp has no effect on the direction of Armata Pharmaceuticals i.e., Armata Pharmaceuticals and PDS Biotechnology go up and down completely randomly.
Pair Corralation between Armata Pharmaceuticals and PDS Biotechnology
Given the investment horizon of 90 days Armata Pharmaceuticals is expected to generate 0.51 times more return on investment than PDS Biotechnology. However, Armata Pharmaceuticals is 1.96 times less risky than PDS Biotechnology. It trades about -0.01 of its potential returns per unit of risk. PDS Biotechnology Corp is currently generating about -0.04 per unit of risk. If you would invest 207.00 in Armata Pharmaceuticals on November 8, 2024 and sell it today you would lose (3.00) from holding Armata Pharmaceuticals or give up 1.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Armata Pharmaceuticals vs. PDS Biotechnology Corp
Performance |
| Timeline |
| Armata Pharmaceuticals |
| PDS Biotechnology Corp |
Armata Pharmaceuticals and PDS Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Armata Pharmaceuticals and PDS Biotechnology
The main advantage of trading using opposite Armata Pharmaceuticals and PDS Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Armata Pharmaceuticals position performs unexpectedly, PDS Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PDS Biotechnology will offset losses from the drop in PDS Biotechnology's long position.The idea behind Armata Pharmaceuticals and PDS Biotechnology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |